Additionally, mutations in p53, one of the most frequently mutated tumor suppressor genes in human cancers, have been observed in close to half of adenocarcinomas, often in conjunction with activating mutations in EGFR or KRAS [4]. Here, TP53 is linked to adenocarcinoma.